trelegy 100 ellipta 14 doses (テリルジー100エリプタ14吸入用)
glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation
trelegy 100 ellipta 30 doses (テリルジー100エリプタ30吸入用)
glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation
trelegy 200 ellipta 14 doses (テリルジー200エリプタ14吸入用)
glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation
trelegy 200 ellipta 30 doses (テリルジー200エリプタ30吸入用)
glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation
anoro ellipta inhalation powder 62.5 mcg25 mcg
glaxosmithkline pte ltd - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol - powder, metered - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium 62.5 mcg/dose; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol 25 mcg/dose
incruse ellipta (previously incruse)
glaxosmithkline (ireland) limited - umeclidinium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).,
rolufta ellipta (previously rolufta)
glaxosmithkline trading services limited - umeclidinium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - rolufta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).,
incruse ellipta
glaxosmithkline nz limited - umeclidinium bromide 74.2ug equivalent to umeclidinium 62.5 mcg; - powder for inhalation - 62.5 mcg - active: umeclidinium bromide 74.2ug equivalent to umeclidinium 62.5 mcg excipient: lactose monohydrate magnesium stearate - incruse ellipta is indicated as a long-term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).
anoro ellipta 62.5mcg/ 25mcg (equivalent to 55/ 22mcg delivered dose) dry powder for inhalation
glaxosmithkline philippines inc. - umeclidinium bromide , vilanterol (as trifenatate) - dry powder for inhalation - 62.5mcg/ 25mcg (equivalent to 55/ 22mcg delivered dose)
anoro ellipta powder for inhalation
glaxo operations uk ltd - umeclidinium (umeclidinium bromide), vilanterol (vilanterol trifenatate) - powder for inhalation - 62.5mcg/dose+ 25mcg/dose